Chapter 30. Sequence-defined Oligonucleotides as Potential Therapeutics
- 1 January 1991
- book chapter
- Published by Elsevier
- Vol. 26, 287-296
- https://doi.org/10.1016/s0065-7743(08)61217-8
Abstract
No abstract availableThis publication has 83 references indexed in Scilit:
- Selective Attachment of Oligonucleotides to Interleukin-1β and Targeted Delivery to CellsNucleosides, Nucleotides and Nucleic Acids, 1990
- Extension of the Life-Span of Human Endothelial Cells by an Interleukin-1αAntisense OligomerScience, 1990
- Enantio-DNA recognizes complementary RNA but not complementary DNAJournal of the American Chemical Society, 1990
- In vitro selection of RNA molecules that bind specific ligandsNature, 1990
- Porphyrin‐linked oligonucleotidesFEBS Letters, 1990
- Systematic Evolution of Ligands by Exponential Enrichment: RNA Ligands to Bacteriophage T4 DNA PolymeraseScience, 1990
- A new class of antivirals: antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus‐specific proteins in MDCK cellsFEBS Letters, 1990
- Sugar modified oligonucleotides I. Carbo-oligodeoxynucleotides as potential antisense agentsBiochemical and Biophysical Research Communications, 1989
- Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3′‐terminus and their interaction with DNA within mammalian cellsFEBS Letters, 1989
- Complementary addressed modification of double‐stranded DNA within a ternary complexFEBS Letters, 1988